Skye Global Management’s HCA Healthcare HCA Stock Holding History

Skye Global Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-107,000	Closed	-$18M	–	24
2022 Q2	$18M	Buy	+107,000	New	+$23M	0.39%	18

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Skye Global Management's HCA Position: Q3 2022 in Review

Skye Global Management sold out of HCA Healthcare (HCA) in Q3 2022, closing a stake of 107,000 shares — an estimated $18M sold.

Skye Global Management first reported a position in HCA in Q2 2022 and held it in 1 quarter. The position peaked at $18M in Q2 2022. 867 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

Skye Global Management reported no remaining HCA Healthcare position as of Q3 2022 after selling out during the quarter.
Skye Global Management sold 107,000 HCA Healthcare shares in Q3 2022, an estimated $18M.
Skye Global Management first reported a position in HCA Healthcare in Q2 2022 and held it in 1 quarter.
Skye Global Management's HCA Healthcare position peaked at $18M in Q2 2022.
867 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on Skye Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.